University of Guelph researchers have received $230,000 to develop potential COVID-19 vaccines under the province’s Ontario Together investment to advance research to combat the pandemic.
University of Guelph researchers have received $230,000 to develop potential COVID-19 vaccines under the province’s Ontario Together investment to advance research to combat the pandemic.
Pathobiology professor Byram Bridle said he believes the team’s vaccine platform – adapted from U of G research into vaccines as cancer therapies — will be a leading candidate among the roughly 120 Canadian projects currently racing to develop an effective vaccine against the pandemic virus.
This project is one of 15 included in today’s provincial funding announcement and is the only one aimed at developing a vaccine.
“We have been focused on cancer for years, but this collaboration shows the flexibility of the technology we have at Guelph,” he said. “We can rapidly apply cancer technology and move it over to infectious disease.”
Read more at University of Guelph
Image: Prof. Byram Bridle (Credit: University of Guelph)
